Improved responses to pegylated interferon alfa-2b and ribavirin by individualizing treatment for 24-72 weeks - Sarrazin, Christoph; Schwendy, Susanne; Möller, Bernd; Dikopoulos, Nektarios; Buggisch, Peter; Encke, Jens; Teuber, Gerlinde; Goeser, Tobias; Thimme, Robert; Klinker, Hartwig; Boecher, Wulf O.; Schulte-Frohlinde, Ewert; et al. (Gastroenterology, 2011)
Gesehen am 06.10.2022